Dose-finding study of AJG533 in patients with chronic constipation (Phase 2 study)
Latest Information Update: 09 May 2019
At a glance
- Drugs Elobixibat (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Ajinomoto Pharma
- 09 May 2017 Primary endpoint "Frequency of Spontaneous Bowel Movement" has been met as per results published in the Digestive Disease Week 2017.
- 09 May 2017 Results presented at the Digestive Disease Week 2017
- 27 Apr 2017 Results from this trial will be presented at Digestive Disease Week (DDW) 2017, according to an Albireo Pharmaceuticals media release.